Nasopharyngeal Carcinoma — Trials

Nasopharyngeal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

702 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 246
Recruiting: 131
Ph III recruiting: 54
Growth YoY: +5.4%
Industry share: 8%
Top sponsor: Sun Yat-sen University
Termination share: 22.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (35)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05531916	Compression Therapy as a Prophylactic Method Against CIPN: a Prospective Self-controlled Trial(CIPN)	active not recruiting	N/A	182	Sun Yat-sen UniversityOTHER	1	Apr 30, 2026	clinicaltrials
NCT07248696	Tislelizumab Plus Chemotherapy With Response-Adapted Radiotherapy for de Novo Metastatic Nasopharyngeal Carcinoma: A Prospective, Phase II Trial	active not recruiting	N/A	32	Chongqing University Cancer HospitalOTHER	1	Nov 25, 2025